LISATA THERAPEUTICS, INC. (LSTA) Form 10-K Annual Reports
LISATA THERAPEUTICS, INC. (LSTA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LSTA
CIK: 320017
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerSara D'Agostino
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3 | 2026-10-15 | 2026-10-13 | FORM 3 | 0001140361-26-039795 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-13 | 8-K | 0001140361-26-039602 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-07 | 2026-11-09 | PRE 14A | 0001140361-26-038937 | View SEC Doc Filr Page |
| D | 2026-10-02 | — | D Filing | 0000320017-26-000039 | View SEC Doc Filr Page |
| 3 | 2026-09-28 | 2026-09-17 | FORM 3 | 0001140361-26-037879 | View SEC Doc Filr Page |
| 3 | 2026-09-28 | 2026-09-17 | FORM 3 | 0001140361-26-037878 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-17 | 8-K | 0001140361-26-036866 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-26 | — | SCHEDULE 13G Filing | 0002150037-26-000001 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0000320017-26-000038 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-03 | 8-K | 0001140361-26-031028 | View SEC Doc Filr Page |
| SC TO-T/A | 2026-07-28 | — | SC TO-T/A | 0001140361-26-029893 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-24 | 8-K | 0001140361-26-029541 | View SEC Doc Filr Page |
| SC 14D9/A | 2026-07-21 | — | SC 14D9/A | 0001140361-26-029022 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-16 | 8-K | 0001140361-26-028763 | View SEC Doc Filr Page |
| SC 14D9/A | 2026-07-17 | — | SC 14D9/A | 0001140361-26-028761 | View SEC Doc Filr Page |
| SC TO-T/A | 2026-07-17 | — | SC TO-T/A | 0001140361-26-028733 | View SEC Doc Filr Page |
| SC 14D9/A | 2026-07-13 | — | SC 14D9/A | 0001140361-26-028257 | View SEC Doc Filr Page |
| SC TO-T/A | 2026-07-10 | — | SCHEDULE TO-T/A | 0001140361-26-028238 | View SEC Doc Filr Page |
| SC 14D9/A | 2026-07-02 | — | SC 14D9/A | 0001140361-26-027435 | View SEC Doc Filr Page |
| SC 14D9 | 2026-06-10 | — | SC 14D9 | 0001140361-26-024737 | View SEC Doc Filr Page |
| SC TO-T | 2026-06-10 | — | SC TO-T | 0001140361-26-024731 | View SEC Doc Filr Page |
| SC14D9C | 2026-06-09 | — | SC14D9C | 0001140361-26-024561 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-08 | 8-K | 0001140361-26-024560 | View SEC Doc Filr Page |
| SC TO-C | 2026-06-01 | — | SC TO-C | 0001140361-26-023433 | View SEC Doc Filr Page |
| SC14D9C | 2026-06-01 | — | SC14D9C | 0001140361-26-023404 | View SEC Doc Filr Page |